[18F]-F13640
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for [18F]-F13640, covering 2025-09-12 to 2025-09-12. Get the full timeline:
Most recent: Clinical Trial Update: [18F]-F13640 as a New Brain Radiopharmaceutical [EARLY_Phase 1]